GENERALIZED ANXIETY DISORDER

This study tests a single dose of an experimental drug called SYT-510 in 24 adults with generalized anxiety disorder. Researchers will use brain scans and behavioral tasks to see if the drug reduces anxiety and changes how the brain responds to threats. The goal is to gather info…

This study tests whether a single injection of a new drug called RE104 can reduce anxiety symptoms in people with Generalized Anxiety Disorder (GAD). About 64 adults with GAD will receive either RE104 or a placebo, and their anxiety levels will be measured after 4 weeks. The goal…

This study looks at whether electroacupuncture (a type of acupuncture with mild electric pulses) can reduce anxiety symptoms in people with Generalized Anxiety Disorder. About 123 adults will receive either real electroacupuncture, fake electroacupuncture, or no extra treatment, …

This study tests a non-invasive brain stimulation method called cTBS to see if it can reduce anxiety in people with Generalized Anxiety Disorder. 60 adults will receive either real or placebo stimulation to two brain areas over seven days. The goal is to measure changes in anxiet…

This study aims to find out if very short psychological treatments can effectively reduce symptoms of anxiety, depression, and stress-related physical symptoms. Researchers will compare four different approaches: group therapy lasting eight sessions, group therapy lasting four se…

This study interviews 30 adults with generalized anxiety, social anxiety, or PTSD who previously completed a trial comparing two therapies: metacognitive therapy and cognitive-behavioral therapy. The goal is to learn what participants thought about each treatment to help doctors …

This early-stage study looks at how the body processes buagafuran, an experimental drug for generalized anxiety disorder, in people with liver impairment compared to those with normal liver function. Twenty-four adults will receive a single dose to measure drug levels and safety.…